BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mamelak M. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Prog Neurobiol 2009;89:193-219. [PMID: 19654034 DOI: 10.1016/j.pneurobio.2009.07.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Donjacour CE, Aziz NA, Roelfsema F, Frölich M, Overeem S, Lammers GJ, Pijl H. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls. Am J Physiol Endocrinol Metab 2011;300:E1069-75. [PMID: 21447786 DOI: 10.1152/ajpendo.00623.2010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
2 Brennan R, Van Hout MC. Gamma-Hydroxybutyrate (GHB): A Scoping Review of Pharmacology, Toxicology, Motives for Use, and User Groups. Journal of Psychoactive Drugs 2014;46:243-51. [DOI: 10.1080/02791072.2014.921746] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
3 Kamal RM, Schellekens A, De Jong CA, Dijkstra BA. Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study. BMC Psychiatry 2015;15:91. [PMID: 25927622 DOI: 10.1186/s12888-015-0471-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
4 Scrima L. Dreaming Epiphenomena of Narcolepsy. Sleep Medicine Clinics 2010;5:261-75. [DOI: 10.1016/j.jsmc.2010.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Hein M, Lanquart JP, Mungo A, Hubain P, Loas G. Impact of number of sleep ultradian cycles on polysomnographic parameters related to REM sleep in major depression: Implications for future sleep research in psychiatry. Psychiatry Res 2020;285:112818. [PMID: 32035377 DOI: 10.1016/j.psychres.2020.112818] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mourand I, Escuret E, Héroum C, Jonquet O, Picot M, Mercier G, Milhaud D. Feasibility of hypothermia beyond 3weeks in severe ischemic stroke. Journal of the Neurological Sciences 2012;316:104-7. [DOI: 10.1016/j.jns.2012.01.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
7 Roth T, Dauvilliers Y, Mignot E, Montplaisir J, Paul J, Swick T, Zee P. Disrupted nighttime sleep in narcolepsy. J Clin Sleep Med 2013;9:955-65. [PMID: 23997709 DOI: 10.5664/jcsm.3004] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 12.0] [Reference Citation Analysis]
8 Hassan Z, Bosch OG, Singh D, Narayanan S, Kasinather BV, Seifritz E, Kornhuber J, Quednow BB, Müller CP. Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Front Psychiatry 2017;8:152. [PMID: 28868040 DOI: 10.3389/fpsyt.2017.00152] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
9 Kamal RM, van Noorden MS, Wannet W, Beurmanjer H, Dijkstra BA, Schellekens A. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs 2017;31:51-64. [PMID: 28004314 DOI: 10.1007/s40263-016-0402-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
10 Roll JM, Newton T, Chudzynski J, Cameron JM, McPherson S, Fong T, Torrington M. Preference for gamma-hydroxybutyrate (GHB) in current users. J Exp Anal Behav 2012;97:323-31. [PMID: 22693361 DOI: 10.1901/jeab.2012.97-323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Bosch OG, Seifritz E. The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans. Brain Res Bull 2016;126:47-60. [PMID: 26855327 DOI: 10.1016/j.brainresbull.2016.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
12 Bae SM, Lee YJ, Cho IH, Kim SJ, Im JS, Cho SJ. Risk factors for suicidal ideation of the general population. J Korean Med Sci 2013;28:602-7. [PMID: 23579548 DOI: 10.3346/jkms.2013.28.4.602] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
13 Marclay F, Saudan C, Vienne J, Tafti M, Saugy M. Source inference of exogenous gamma-hydroxybutyric acid (GHB) administered to humans by means of carbon isotopic ratio analysis: novel perspectives regarding forensic investigation and intelligence issues. Anal Bioanal Chem 2011;400:1105-12. [DOI: 10.1007/s00216-011-4891-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
14 Dornbierer DA, Boxler M, Voegel CD, Stucky B, Steuer AE, Binz TM, Baumgartner MR, Baur DM, Quednow BB, Kraemer T, Seifritz E, Landolt HP, Bosch OG. Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers. Int J Neuropsychopharmacol 2019;22:631-9. [PMID: 31504554 DOI: 10.1093/ijnp/pyz047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Luca F, Sarah B, Maria Cristina T, Tiziana A, Antonella L, Sergio T. GET73 modulates rat hippocampal glutamate transmission: evidence for a functional interaction with mGluR5. Pharmacological Reports 2011;63:1359-71. [DOI: 10.1016/s1734-1140(11)70700-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Rodrigues Aguilar AC, Frange C, Huebra L, Dias Gomes AC, Tufik S, Santos Coelho FM. The effects of the COVID-19 pandemic on patients with narcolepsy. J Clin Sleep Med 2021;17:621-7. [PMID: 33124977 DOI: 10.5664/jcsm.8952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Kim KJ, Pearl PL, Jensen K, Snead OC, Malaspina P, Jakobs C, Gibson KM. Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance. Antioxid Redox Signal 2011;15:691-718. [PMID: 20973619 DOI: 10.1089/ars.2010.3470] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
18 Dornbierer DA, Baur DM, Stucky B, Quednow BB, Kraemer T, Seifritz E, Bosch OG, Landolt HP. Neurophysiological signature of gamma-hydroxybutyrate augmented sleep in male healthy volunteers may reflect biomimetic sleep enhancement: a randomized controlled trial. Neuropsychopharmacology 2019;44:1985-93. [PMID: 30959514 DOI: 10.1038/s41386-019-0382-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
19 Domínguez I, Bruguera P, Balcells-Oliveró M, Batalla A. Depression Following γ-Hydroxybutyrate Withdrawal: A Case Report. J Clin Psychopharmacol 2015;35:618-9. [PMID: 26284931 DOI: 10.1097/JCP.0000000000000394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Bosch OG, Esposito F, Dornbierer D, von Rotz R, Kraehenmann R, Staempfli P, Quednow BB, Seifritz E. Prohedonic properties of gamma-hydroxybutyrate are associated with changes in limbic resting-state functional connectivity. Hum Psychopharmacol 2018;33:e2679. [PMID: 30426556 DOI: 10.1002/hup.2679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Korpi ER, den Hollander B, Farooq U, Vashchinkina E, Rajkumar R, Nutt DJ, Hyytiä P, Dawe GS, Koulu M. Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse. Pharmacol Rev 2015;67:872-1004. [DOI: 10.1124/pr.115.010967] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 11.7] [Reference Citation Analysis]
22 Chien J, Ostermann G, Turkel SB. Sodium oxybate-induced psychosis and suicide attempt in an 18-year-old girl. J Child Adolesc Psychopharmacol 2013;23:300-1. [PMID: 23647134 DOI: 10.1089/cap.2012.0130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
23 Pehrson AL, Sanchez C. Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug Des Devel Ther 2015;9:603-24. [PMID: 25653499 DOI: 10.2147/DDDT.S62912] [Cited by in Crossref: 88] [Cited by in F6Publishing: 40] [Article Influence: 12.6] [Reference Citation Analysis]
24 Wellendorph P, Høg S, Sabbatini P, Pedersen MH, Martiny L, Knudsen GM, Frølund B, Clausen RP, Bräuner-Osborne H. Novel radioiodinated {gamma}-hydroxybutyric acid analogues for radiolabeling and Photolinking of high-affinity {gamma}-hydroxybutyric acid binding sites. J Pharmacol Exp Ther 2010;335:458-64. [PMID: 20696866 DOI: 10.1124/jpet.110.170670] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
25 Kripke DF. Is suvorexant a better choice than alternative hypnotics? F1000Res 2015;4:456. [PMID: 26594338 DOI: 10.12688/f1000research.6845.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
26 Sasai-Sakuma T, Inoue Y. Differences in electroencephalographic findings among categories of narcolepsy-spectrum disorders. Sleep Med 2015;16:999-1005. [PMID: 26026626 DOI: 10.1016/j.sleep.2015.01.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
27 Felmlee MA, Roiko SA, Morse BL, Morris ME. Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid. J Pharmacol Exp Ther 2010;333:764-71. [PMID: 20215411 DOI: 10.1124/jpet.109.165381] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
28 Landolt HP, Holst SC, Valomon A. Clinical and Experimental Human Sleep-Wake Pharmacogenetics. Handb Exp Pharmacol 2019;253:207-41. [PMID: 30443785 DOI: 10.1007/164_2018_175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Maitre M, Klein C, Mensah-Nyagan AG. Mechanisms for the Specific Properties of γ-Hydroxybutyrate in Brain. Med Res Rev 2016;36:363-88. [PMID: 26739481 DOI: 10.1002/med.21382] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
30 Bosch OG, Esposito F, Dornbierer D, Havranek MM, von Rotz R, Kometer M, Staempfli P, Quednow BB, Seifritz E. Gamma-hydroxybutyrate increases brain resting-state functional connectivity of the salience network and dorsal nexus in humans. Neuroimage 2018;173:448-59. [PMID: 29524621 DOI: 10.1016/j.neuroimage.2018.03.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Allan WL, Breitkreuz KE, Waller JC, Simpson JP, Hoover GJ, Rochon A, Wolyn DJ, Rentsch D, Snedden WA, Shelp BJ. Detoxification of succinate semialdehyde in Arabidopsis glyoxylate reductase and NAD kinase mutants subjected to submergence stress. Botany 2012;90:51-61. [DOI: 10.1139/b11-083] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
32 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
33 Bosch OG, Quednow BB, Seifritz E, Wetter TC. Reconsidering GHB: orphan drug or new model antidepressant? J Psychopharmacol 2012;26:618-28. [DOI: 10.1177/0269881111421975] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
34 Black SW, Morairty SR, Chen TM, Leung AK, Wisor JP, Yamanaka A, Kilduff TS. GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy. J Neurosci 2014;34:6485-94. [PMID: 24806675 DOI: 10.1523/JNEUROSCI.0080-14.2014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
35 Mamelak M. Energy and the Alzheimer brain. Neurosci Biobehav Rev 2017;75:297-313. [PMID: 28193453 DOI: 10.1016/j.neubiorev.2017.02.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
36 Bosch OG, Esposito F, Havranek MM, Dornbierer D, von Rotz R, Staempfli P, Quednow BB, Seifritz E. Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans. Neuropsychopharmacology 2017;42:2141-51. [PMID: 28561068 DOI: 10.1038/npp.2017.110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
37 Zhou Y, Yang J, Liu J, Wang Y, Zhang WS. Efficacy comparison of the novel water-soluble propofol prodrug HX0969w and fospropofol in mice and rats. Br J Anaesth 2013;111:825-32. [PMID: 23801745 DOI: 10.1093/bja/aet218] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
38 Rotter A, Bayerlein K, Hansbauer M, Weiland J, Sperling W, Kornhuber J, Biermann T. Orexin A expression and promoter methylation in patients with cannabis dependence in comparison to nicotine-dependent cigarette smokers and nonsmokers. Neuropsychobiology 2012;66:126-33. [PMID: 22846875 DOI: 10.1159/000339457] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
39 Nasrallah FA, Maher AD, Hanrahan JR, Balcar VJ, Rae CD. γ-Hydroxybutyrate and the GABAergic footprint: a metabolomic approach to unpicking the actions of GHB. J Neurochem 2010;115:58-67. [PMID: 20681954 DOI: 10.1111/j.1471-4159.2010.06901.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]